More than 12 African heads of state and other global leaders met today and reviewed progress toward implementing transformative reforms in the AIDS, Tuberculosis (TB) and malaria responses and pledged to accelerate the pace of change (increase annual domestic funding for health care, particularly AIDS, TB and malaria services). AIDS Watch Africa (AWA), an advocacy platform for African Heads of State on AIDS, TB and Malaria convened the meeting in Addis Ababa, Ethiopia on the side-lines of the African Union summit celebrating 50 years of African Unity.
My colleague the Deputy Minister of Health
MECs for Health present
The Chairperson and members of the Health Portfolio Committee
Honourable Members of Parliament
Ladies and Gentlemen
Honourable Speaker, it is now well documented and generally understood that South Africa faces a quadruple burden of disease. Many other countries are faced only with a double burden.
These four are:
TB is linked with a deadly silicosis epidemic hidden for decades in rural South Africa. Gold mining firms must make amends, says Jaine Roberts.
Across the rural Eastern Cape province in South Africa, up to half of men admitted to hospital withtuberculosis (TB) are former gold miners. This should not be surprising: the incidence of TB among miners is 2,000 cases per 100,000, four times the national incidence.
But researchers rarely ask about occupation when studying the distribution and determinants of illnesses such as TB — and the result here is a hidden epidemic of silicosis-related TB among former gold miners in South Africa.
South Africa will expand its rollout of GeneXpert tuberculosis (TB) testing machines, which can diagnose TB and drug-resistant TB within 90 minutes, but concerns remain about the capacity to back up this commitment with supplies and treatment.
The country is the largest buyer of GeneXpert technology in the world, but the machines have not yet become point-of-care tests and are often deployed at district rather than clinic level. Nonetheless, they have shaved weeks off waiting times for patients because samples no longer have to be transported to and from national referral hospitals kilometres away for diagnosis.
SOUTH Africa and the Southern African Development Community (Sadc) have less than 1,000 days to significantly reduce the impact of the tuberculosis (TB) and HIV co-epidemic in the region to meet the United Nations (UN) Millennium Development Goals (MDG) deadline in 2015.
Sadc health ministers and nongovernmental organisations (NGOs) will join a delegation in Mbabane, Swaziland, on Thursday to discuss the co-epidemic as well as its impact on labour in the region’s mining sector.
Organisations at a briefing in Johannesburg on Wednesday committed about $860m to fighting the TB epidemic in Sadc.
The Swaziland meeting will also look to put in motion recommendations in the Sadc declaration on TB in the mining sector, signed last year.
EXCLUSIVE: Researchers have identified a new strain of tuberculosis in 17 patients in the Eastern Cape which is totally resistant to the all current drug regimens.
Screening every inmate for TB, treating them upon diagnosis - coupled with improved cell ventilation and an urgent focus on alleviating overcrowding are the cornerstones of government’s plans to tackle this curable disease, deputy president Kgalema Motlanthe told a group of Pollsmoor inmates yesterday (SUNDAY).
Arguably South Africa’s most overcrowded prison with an unsurprisingly high TB prevalence, Pollsmoor was yesterday the focus of government’s World TB Day events attended by Motlanthe, health minster Dr Aaron Motsoaledi and Correctional Services minster Sbu Ndebele.
The HIV/AIDS epidemic arrived in sub-Saharan Africa after decades of neglect had left healthcare systems dangerously weak, barely able to cope with the onslaught of patients. Then the money started pouring in - funding for HIV programmes rose from 5.5 percent of health aid in 1998 to nearly half of it almost 10 years later.
DESPITE the tight fiscal environment, the health sector will receive additional funding over the medium term to compensate for a drop in US donor support for HIV/AIDS programmes, expand HIV treatment and improve the diagnosis of tuberculosis (TB).
Consolidated government health expenditure is set to rise from R138bn in 2013-14 to R148bn in 2014-15 and R157bn in 2015-16.
An extra R800m has been allocated to the baseline for the provision of antiretroviral drugs over the medium-term expenditure framework, with the government planning to put an extra 500,000 people on treatment each year. Currently, about 2-million people receive treatment.
A massive population-based study launched in the Western Cape and Zambia yesterday is aiming to answer the critical question whether testing large populations for HIV and immediately starting those infected on effective antiretroviral treatment programmes, could close the tap on new infections.
The study, HPTN071 (PopART) will aim to find out whether offering a combination of several HIV prevention methods to a community will better prevent the spread of HIV that the standard individual methods currently on offer.